The deadly meningitis outbreak that has quickly spread across the U.S. was the result of one specialty pharmacy. The New England Compounding Center (NECC) made a steroid that was used for back pain and shipped over 17,000 doses of the steroid to many clinics in at least 23 states.
What Went Wrong?
As many as 13,000 people already have received these shots; however, the medication was contaminated. Compounding pharmacies, like this one, are supposed to make and supply medicines that are not commercially available. However, compounding should only be done in response to a specific patient prescription and not made in mass quantities, according to health regulations.
Officials are investigating this case, as it seems the New England Compounding Center was operating across state lines and supplying prescriptions to hundreds of hospitals and clinics. It appears to many officials that this facility crossed the line by supplying drugs widely without individual prescriptions in hand. When they dispense drugs on a large scale, they essentially become small pharmaceutical companies that adhere to different regulations.
Because compounding pharmacies are exempt from traditional review by the Food and Drug Administration (FDA), the steroid doses were not reviewed and approved by the FDA or any regulating body. When compounding pharmacies overstep their bounds and act as a manufacturer, they sneak in below the FDA’s radar.
In this situation, this pharmacy may have misled regulators by doing work that was beyond their license. Sadly, deaths and injuries could have been prevented if the compounding pharmacy wasn’t acting like a mini pharmaceutical company or manufacturer. To bring a pharmacy error claim against NECC, call a skilled drug error lawyer at Kennedy Hodges at 888-526-7616 for a free consultation today. Also, make sure you download a FREE copy of our report, How to Make Pharmacies Pay for Injuries Caused by Medication Errors.